Last reviewed · How we verify
NCT03746730
Role of US,Doppler in Major Salivary Gland Diseases
trial testing ultrasound in Salivary Gland Diseases in 40 participants. Status unknown.
1 September 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 December 2018 |
| Primary completion | 1 September 2020 |
| Estimated completion | 1 October 2020 |
Drugs / interventions tested
- ultrasound
Conditions studied
- Salivary Gland Diseases — all drugs for Salivary Gland Diseases →
Sponsor
Assiut University
Who can join
Eligibility, any sex, with Salivary Gland Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the role of gray scale and Doppler ultrasound in characterizing of parotid and submandibular gland lesions in comparison to biopsy if needed
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03746730
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ultrasound
Trials testing the same drug.
- NCT07473908 — Ultrasound Assessment of Achilles Tendon-Neurovascular Distance in Infants With Unilateral Clubfoot · not yet recruiting
- NCT07408596 — "Ultrasound Measures and Clinical Outcomes in Healthy Individuals, Mild and Moderate Carpal Tunnel Syndrome Patients" · completed
- NCT06901063 — Research of Brachial Plexus Anatomy · completed
- NCT07351292 — Ultrasound or Whole Body Vibration on Knee Motion and Function in CP · NA · completed
- NCT06576128 — Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03746730 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 20 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03746730.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing